Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

YMAB Y mAbs Therapeutics Inc

6,09

-0,06 (-0,98%)

28 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Y mAbs Therapeutics (NASDAQ:YMAB)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Y mAbs Therapeutics Charts.

Y mAbs Therapeutics (NASDAQ:YMAB)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Y mAbs Therapeutics Charts.

News Y mAbs Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 23 Januar 2025 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 23 Januar 2025 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 23 Januar 2025 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 23 Januar 2025 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 23 Januar 2025 (6 Tage vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Freitag 17 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Donnerstag 16 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 10 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Correcting & Replacing – Y-mAbs Provides Strategic Business Update and 2025 Priorities
Freitag 10 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Y-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business Unit
Freitag 10 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Y-mAbs Provides Strategic Business Update and 2025 Priorities
Freitag 10 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Weitere Y mAbs Therapeutics Inc News-Artikel

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen